Treace Medical Concepts

TMCI Micro Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

$1.45

+2.84% today

52W: $1.17 – $8.13

52W Low: $1.17 Position: 4% 52W High: $8.13

🔗 Compare Brokers

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

0.44x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$93.7M

Market Capitalization

Revenue Growth

-9%

YoY Revenue Growth

Profit Margin

-27.74%

Net profit margin

ROE

-58.94%

Return on Equity

Beta

0.88

Market sensitivity

Short Interest

8.08%

% of float sold short

Avg. Volume

732,983

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Hold

4 analysts

Avg. Price Target

$4.25

+193.1% upside

Target Range

$2.00 – $7.00

About the Company

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoa

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 450 Exchange: NMS